abstract |
Some embodiments of the disclosure provides a chimeric antigen receptor (CAR) comprising an antigen binding domain specific for FLT3, an antigen binding domain specific for a second antigen, a transmembrane domain, and an intracellular T cell signaling domain. Some embodiments of the disclosure provides bicistronic CARs. Nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions relating to the CARs are disclosed. Methods of detecting the presence of a proliferative disorder, e.g., cancer, in a mammal and methods of treating or preventing a proliferative disorder, e.g., cancer, in a mammal are also disclosed. |